ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA October 2019 PDF.pdf

Drug Safety Update MHRA October 2019 PDF.pdf
Summary: Ingenol mebutate gel (Picatoâ–¼): increased incidence of skin tumours seen in some clinical studies. Nivolumab (Opdivo): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation. Prescribing medicines in renal impairment: using the appropriate estimate of renal function to avoid the risk of adverse drug reactions. Adrenaline auto-injectors: recent action taken to support safety
File Size: 336KB
File Type: application/pdf
Created: 23 October 2019
Last Modified: 22 November 2019